Literature DB >> 21681604

Cellular and molecular mechanisms in the two major forms of inflammatory bowel disease.

Laszlo Bene1, Andras Falus, Noemi Baffy, Andras Kristof Fulop.   

Abstract

The factors involved in the pathogenesis of Crohn's disease and ulcerative colitis, the two major types of inflammatory bowel disease (IBD) are summarized. Intestinal antigens composed of bacterial flora along with antigen presentation and impaired mucosal barrier have an important role in the initiation of IBD. The bacterial community may be modified by the use of antibiotics and probiotics. The dentritic cells recognize the antigens by cell surface Toll like receptor and the cytoplasmic CARD/NOD system. The balance between Th1/Th2/Th17 cell populations being the source of a variety of cytokines regulates the inflammatory mechanisms and the clearance of microbes. The intracellular killing and digestion, including autophagy, are important in the protection against microbes and their toxins. The homing process determines the location and distribution of the immune cells along the gut. All these players are potential targets of pharmacological manipulation of disease status.

Entities:  

Mesh:

Year:  2011        PMID: 21681604     DOI: 10.1007/s12253-011-9397-4

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  83 in total

Review 1.  Probiotics and inflammatory bowel diseases.

Authors:  A-P Bai; Q Ouyang
Journal:  Postgrad Med J       Date:  2006-06       Impact factor: 2.401

2.  Human IRGM induces autophagy to eliminate intracellular mycobacteria.

Authors:  Sudha B Singh; Alexander S Davis; Gregory A Taylor; Vojo Deretic
Journal:  Science       Date:  2006-08-03       Impact factor: 47.728

3.  Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohn's disease.

Authors:  Peter Laszlo Lakatos; Lajos Sandor Kiss; Karoly Palatka; Istvan Altorjay; Peter Antal-Szalmas; Eszter Palyu; Miklos Udvardy; Tamas Molnar; Klaudia Farkas; Gabor Veres; Jolan Harsfalvi; Janos Papp; Maria Papp
Journal:  Inflamm Bowel Dis       Date:  2010-09-23       Impact factor: 5.325

4.  Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis.

Authors:  M Boirivant; M Marini; G Di Felice; A M Pronio; C Montesani; R Tersigni; W Strober
Journal:  Gastroenterology       Date:  1999-03       Impact factor: 22.682

5.  Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells.

Authors:  J Rodrigo Mora; Maria Rosa Bono; N Manjunath; Wolfgang Weninger; Lois L Cavanagh; Mario Rosemblatt; Ulrich H Von Andrian
Journal:  Nature       Date:  2003-07-03       Impact factor: 49.962

Review 6.  Interleukin-12 and the regulation of innate resistance and adaptive immunity.

Authors:  Giorgio Trinchieri
Journal:  Nat Rev Immunol       Date:  2003-02       Impact factor: 53.106

7.  Expression of Toll-like receptor 2 (TLR2), TLR4, and CD14 in biopsy samples of patients with inflammatory bowel diseases: upregulated expression of TLR2 in terminal ileum of patients with ulcerative colitis.

Authors:  Lenka Frolova; Pavel Drastich; Pavel Rossmann; Klara Klimesova; Helena Tlaskalova-Hogenova
Journal:  J Histochem Cytochem       Date:  2007-11-26       Impact factor: 2.479

8.  Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease.

Authors:  M W Babyatsky; G Rossiter; D K Podolsky
Journal:  Gastroenterology       Date:  1996-04       Impact factor: 22.682

9.  TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function.

Authors:  Liang Zhou; Jared E Lopes; Mark M W Chong; Ivaylo I Ivanov; Roy Min; Gabriel D Victora; Yuelei Shen; Jianguang Du; Yuri P Rubtsov; Alexander Y Rudensky; Steven F Ziegler; Dan R Littman
Journal:  Nature       Date:  2008-03-26       Impact factor: 49.962

10.  Dual binding capacity of mucosal immunoblasts to mucosal and synovial endothelium in humans: dissection of the molecular mechanisms.

Authors:  M Salmi; D P Andrew; E C Butcher; S Jalkanen
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

View more
  7 in total

1.  The oncoprotein and transcriptional regulator Bcl-3 governs plasticity and pathogenicity of autoimmune T cells.

Authors:  Wanhu Tang; Hongshan Wang; Estefania Claudio; Ilaria Tassi; Hye-lin Ha; Sun Saret; Ulrich Siebenlist
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

2.  Bifidobacterium plays a protective role in TNF-α-induced inflammatory response in Caco-2 cell through NF-κB and p38MAPK pathways.

Authors:  Nana Nie; Cui Bai; Shanai Song; Yanyan Zhang; Benzhen Wang; Zipu Li
Journal:  Mol Cell Biochem       Date:  2019-11-18       Impact factor: 3.396

Review 3.  Muramyl dipeptide responsive pathways in Crohn's disease: from NOD2 and beyond.

Authors:  Mohammad Salem; Jakob Benedict Seidelin; Gerhard Rogler; Ole Haagen Nielsen
Journal:  Cell Mol Life Sci       Date:  2012-12-29       Impact factor: 9.261

4.  Angioedema associated with Crohn's disease: response to biologics.

Authors:  Flavio Habal; Vivian Huang
Journal:  World J Gastroenterol       Date:  2012-09-14       Impact factor: 5.742

5.  Excretory/secretory products from Trichinella spiralis adult worms ameliorate DSS-induced colitis in mice.

Authors:  Xiaodi Yang; Yaping Yang; Yunyun Wang; Bin Zhan; Yuan Gu; Yuli Cheng; Xinping Zhu
Journal:  PLoS One       Date:  2014-05-02       Impact factor: 3.240

Review 6.  Inflammatory Bowel Disease: Updates on Molecular Targets for Biologics.

Authors:  Konstantinos H Katsanos; Konstantinos A Papadakis
Journal:  Gut Liver       Date:  2017-07-15       Impact factor: 4.519

Review 7.  New translational and experimental insights into the role of pro-resolving lipid mediators in inflammatory bowel disease.

Authors:  Lívia Bitencourt Pascoal; Bruna Biazon Palma; Fabio Henrique Mendonça Chaim; Marina Moreira de Castro; Tiago Andrade Damázio; Ana Paula Menezes de Freitas Franceschini; Marciane Milanski; Lício Augusto Velloso; Raquel Franco Leal
Journal:  World J Exp Med       Date:  2022-01-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.